Skip to main content
SpringerLink
Log in

Drug Selection and Dosage in Renal Insufficiency

  • Conference paper
Ergebnisse der Inneren Medizin und Kinderheilkunde

Abstract

Patients with renal insufficiency often react abnormally to a number of drugs. Small doses that are perfectly safe under normal conditions may cause severe and even fatal side effects. Too frequently, these untoward reactions are confused with the symptomatology of uremia and their real cause remains unrecognized.

Policlinique de Médecine, Department of Medicine, University of Geneva, Switzerland.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alano, F. A., Webster, G.D.: Acute renal failure and pigmentation due to phenazopyridine (Pyridium). Ann. intern. Med. 72, 89–91 (1970).

    PubMed  Google Scholar 

  • ALEXANDER, W.D., EVANS, V., MACAULAY, A., GALLAGHER, T.F., LONDONS, J.: Metabolism of 35S–labeled antithyroid drugs in man. Brit. med. J. 1969II, 290–291.

    Google Scholar 

  • ALPEN, E.L., MANDEL, H.G., RODWELL, V.W., SMITH, P. K.: The metabolism of 14C carboxyl salicylic acid in the dog and in man. J. Pharmacol, exp. Ther. 102, 150–155 (1951).

    CAS  Google Scholar 

  • ANEX, L., FAVEZ, G., WILLA, C.: Comparaison entre les clearances rénales à l’inuline et au para–amino–hippurate et les concentrations sanguines d’éthambutol. Schweiz. med. Wschr. 102, 126–128 (1972).

    CAS  Google Scholar 

  • ASATOOR, A.M., LONDON, D.R., MILNE, M. D., Simenhoff, M.L.: The excretion of pethidine and its derivatives. Brit. J. Pharmacol. 20, 285–298 (1963).

    PubMed  CAS  Google Scholar 

  • ATUK, N.O., MOSCA, A., Kunin, C.: The use of potentially nephrotoxic antibiotics in the treatment of Gram–negative infections in uremic patients. Ann. intern. Med. 60, 28–38 (1964).

    PubMed  CAS  Google Scholar 

  • AVIOLI, L.V., BIRGE, S., LEE, S.W., SLATOPOLSKY, E.: The metabolic fate of vitamin D3–3H in chronic renal failure. J. clin. Invest. 47, 2239–2252 (1968).

    Article  PubMed  CAS  Google Scholar 

  • AZZOLINI, F., GAZZANIGA, A., LODOLA, E.: Thiophenicol excretion in subjects with renal insufficiency. Int. J. Pharmacol, ther. Toxicol. 34, 303–308 (1970).

    Google Scholar 

  • BAADT, A., CORBIN, E.E., PRIGOT, A.: Observations on the absorption, diffusion and excretion of oleandomycin in human beings. Antibiot. Ann. 72–74 (1956–1957).

    Google Scholar 

  • BACH, J. F., DARDENNE, M.: The metabolism of azathioprine in renal failure. Transplantation 12, 253–259 (1971).

    Article  PubMed  CAS  Google Scholar 

  • BAETHKE, R., GOLDE, G., GAHL, G.: Sulphamethoxazole/Trimethoprim: Pharmacokinetic studies in patients with chronic renal failure. Europ. J. clin. Pharmacol. 4, 233–240 (1972)

    Article  Google Scholar 

  • BALANT, L., ZAHND, G., GORGIA, A., SCHWARZ, R., FABRE, J.: Pharmacokinetics of glipizide in man: influence of renal insufficiency. Diabetologia Suppl. to 9, 331–338 (1973).

    Article  CAS  Google Scholar 

  • BATES, J. H., SCHULTZ, J. C., ABGRANATHY, R. S.: Kanamycin administration in patients with impaired renal function. Clin. Res. 13, 77–82 (1965).

    Google Scholar 

  • BAUR, M.: Zur Pharmakologie des Harnstoffs (Beiträge zum Problem der Urämie). Arch, exp. Path. Pharmakol. 167, 104–114 (1932).

    Google Scholar 

  • BECKMANN, R.: The fate of biguanides in man. Ann. N.Y. Acad. Sei. 148, 820–832 (1968).

    Article  CAS  Google Scholar 

  • BENNETT, W.M., SINGER, I., COGGINS, C.H.: A practical guide to drug usage in adult patients with impaired renal function. J. Amer. med. Ass. 214, 1468–1475 (1970).

    Article  CAS  Google Scholar 

  • BERENBAUM, M.C.: Immunosuppressive agents and allogenic renal transplantation. J. clin. Path. 20, 471–498 (1968).

    Google Scholar 

  • BERGER, W.: Achtundachtzig schwere Hypoglykämiezwischenfälle unter der Behandlung mit Sulfonylharnstoff. Schweiz, med. Wschr. 71, 1013–1022 (1971).

    Google Scholar 

  • BERNARD, B., YIN, E.J., SIMON, H.J.: Clinical pharmacologic studies with minocycline. J. clin. Pharmacol. 11, 332–348 (1971).

    CAS  Google Scholar 

  • BEYER, K.H., BAER, J.E., MICHAELSON, J.K., RUSSO, H.F.: Renotropic caracteristics of ethacrynic acid, a phenoxyacetic saluretic-diuretic agent. J. Pharmacol, exp. Ther. 147, 1–22 (1965).

    CAS  Google Scholar 

  • BLOOM, P.M., NELP, W.P.: Relationship of the excretion of tritiated digoxin to renal function. Amer. J. med. Sei. 251, 133–144 (1966).

    Article  CAS  Google Scholar 

  • BOISSIER, J.R., SIMON, P., LWOFF, J.M., BRETEAU, M.: Action d’un sulfamide diurétique (Clopamide) chez le rat en insuffisance rénale chronique expérimentale. Thérapie 20, 393–399 (1965).

    PubMed  CAS  Google Scholar 

  • BOLT, W., von RITZL, F., TOUSSAINT, R., NAHRMANN, H.: Verteilung und Ausscheidung eines cytostatisch Wirkenden mit Tritium markierendem N-Lost-Derivatives beim Krebskranken Menschen. Arzneim.-Forsch. 11, 170–175 (1961).

    CAS  Google Scholar 

  • BOVET, D., BOVET-NITTI, F., GUARINO, S., LONGO, V. G., FUSCO, R.: Recherches sur les poisons curarisants de synthèse. III. Succinylcholine et dérivés aliphatiques. Arch. int. Pharmacodyn. 88, 1–50 (1951).

    CAS  Google Scholar 

  • BRASS, H.: Zur Therapie mit Herzglycosiden bei Patienten mit Niereninsuffizienz. Dtsch. med. Wschr. 95, 754–758 (1970).

    CAS  Google Scholar 

  • BRETTELL, H. R., AIKAWA, J.K., GORDON, G.S.: Studies with chlorothiazide tagged with radioactive carbon (C14) in human beings. Arch, intern. Med. 106, 57–63 (1960).

    CAS  Google Scholar 

  • BRETTELL, H. R., SMITH, J. G., AIKAWA, J.K.: Clinical studies with S35 benzydroflumethiazide. Clin. Res. 11, 238 (abstr.) (1963).

    Google Scholar 

  • BRIDGMAN, J.F., ROSEN, S.M., THORP, J.M.: Complications during Clofibrate treatment of nephrotic syndrome hyperlipoproteinemia. Lancet 1972II, 506–509.

    Google Scholar 

  • BRODIE, B.B., ARONOW, L., AXELROD, J.: The fate of benzazoline (Priscolinal) in dog and man and a method for its estimation in biological material. J. Pharmacol, exp. Ther. 106, 200–207 (1952).

    CAS  Google Scholar 

  • BRODIE, B.B., BAER, J. E., CRAIG, L.C.: Metabolic products of the cinchona alkaloids in human urine. J. biol. Chem. 188, 576–580 (1951).

    Google Scholar 

  • BRODIE, B.B., BAEVEN, M.A.: Neurochemical transducer systems. Med. Exp. (Basle), 8, 320–351 (1963).

    CAS  Google Scholar 

  • BRODIE, B.B., LIEF, P. A., POET, R.: The fate of procaine in man following its intravenous administration and methods for the estimation of procaine and diethylamino-ethanol. J. Pharmacol, exp. Ther. 94, 359–366 (1948).

    CAS  Google Scholar 

  • BROUET, G., GODEAU, P., BERGOGNE, E.: Dosage de L’isoniazide libre dans le sérum sanguin dans le traitement de la tuberculose. Intérêt pratique. Thérapie 16, 393–410 (1961).

    Google Scholar 

  • BROUET, G., MARCHE, J.: Les complications d’ordre métabolique et endocrinien produites par la chimiothérapie antibacillaire. Rev. Tuberc. (Paris) 28, 5–76 (1964).

    CAS  Google Scholar 

  • BROWNLEE, G., BUSHBY, S. R., SHORT, E. I.: Chemotherapy and pharmacology of polymyxins. Brit. J. Pharmacol. 7, 170–188 (1952).

    PubMed  CAS  Google Scholar 

  • BRUNNER, F. P., FRICK, F. G.: Hypokalemia, metabolic alkalosis, and hypernatremia due to “massive” sodium penicillin therapy. Brit. med. J. 1968IV, 550–552.

    Google Scholar 

  • BUHS, R. P., BECK, J. L., SPETH, O.C., SMITH, J. L., TRENNER, N.R., CANNON, P. J., LARAGH, J.H.: The metabolism of methyldopa in hypertensive human subjects. J. Pharmacol, exp. Ther. 143, 205–214 (1964).

    CAS  Google Scholar 

  • BULGER, R.J., LINDHOLM, D.D., MURRAY, J.S., KIRBY, W.M.M.: Effect of uremia on methicillin and oxacillin blood levels. J. amer. med. Ass. 187, 319–322 (1964).

    Article  CAS  Google Scholar 

  • BUNKER, J.B., BEECHER, H.K., BRIGGS, B.D., et al.: Metabolic effects of anesthesia. A comparison of acide-base equilibrium in man and in dog during ether and during cyclopropane anesthesis. J. Pharmacol, exp. Therap. 102, 62–70 (1951).

    CAS  Google Scholar 

  • BURCH, O., RAY, T., THREEFOOT, S., KELLY, E. J., SVEDBURG, A.: The urinary excretion and biologic decay periods of radiomercury labelling a mercurial diuretic in normal and diseased man. J. clin. Invest. 29, 1131–1138 (1950).

    Article  PubMed  CAS  Google Scholar 

  • BURNETT, C.H., BLOOMBERG, E.L.: Comparison of effects of ether and cyclopropane anesthesia on renal function in man. J. Pharmacol, exp. Ther. 96, 380–387 (1949).

    CAS  Google Scholar 

  • BURNS, J. J., ROSE, R., GOODWIN, S., REICHENTHAL, J., HORNING, E.C., BRODIE, B.: The metabolic fate of phenylbutazone in man. J. Pharmacol, exp. Ther. 113, 481–489 (1955).

    CAS  Google Scholar 

  • BUTIKOFER, E., et al.: Über die Eliminierungsgeschwindigkeit von Glutethimid (Doriden) und die Natur der Ausscheidungsprodukte beim Mensch. Arch. exp. Path. Pharmakol. 244, 97–102 (1962).

    Article  Google Scholar 

  • BUTLER, T.C.: Quantitative studies of the demethylation of trimethadione (Tridione). J. Pharmacol, exp. Ther. 108, 11–17 (1953).

    CAS  Google Scholar 

  • BUTTNER, H., PORTWICK, F., MANZKE, R., STAUDT, N.: Zur Pharmakokinetik von Sulfonamiden unter pathologischen Bedingungen. Klin. Wschr. 42, 103–108 (1964).

    Article  Google Scholar 

  • CALABRESI, P.: Current status of clinical investigations with 6-azauridine, 5-iodo-2-deoxy- uridine, and related derivatives. Cancer Res. 23, 1260–1267 (1963).

    PubMed  CAS  Google Scholar 

  • CAMERON, J.S., TOSELAND, P.A., READ, J.F.: Accumulation of barbitone in patients on regular hemodialysis. Lancet 1970I, 912–914.

    Google Scholar 

  • CARAPS, S., CODINA, A., CASTELLS, A.: Sindrome extrapyramidal por metoclopramide en enfermos con insuficiency renal avanzada. Rev. clin. esp. 123, 365–368 (1971).

    Google Scholar 

  • CASTAIGNE, J.: La perméabilité méningée dans l’urémie nerveuse. C. R. Soc. Biol. 52, 907–911 (1900).

    Google Scholar 

  • CAWTHORNE, T., RANGER, D.: Toxic effect of streptomycin upon balance and hearing. Brit, med. J. 1957I, 1444-1446.

    Google Scholar 

  • CHAN, R.A., BENNER, E. J., HOEPRICH, P.D.: Gentamicin therapy in renal failure: a normo- gram for dosage. Ann. intern. Med. 78, 773–778 (1972).

    Google Scholar 

  • CHARLES, M. A., DANFORTH, J.R.: Nonketoacidotic hyperglycemia and coma during intravenous diazoxide therapy in uremia. Diabetes 20, 501–503 (1971).

    PubMed  CAS  Google Scholar 

  • CHAVAZ, A., BALANT, L., FABRE, J.: Digoxinémie et digitalisation. Schw. med. Wschr. 104, 65–74 (1974).

    CAS  Google Scholar 

  • CIMINO, J.E., TIERNO, P.M., Jr.: Hemodialysis properties of clindamycin (7-chloro-7-deoxylincomycin). Appl. Microbiol. 17, 446–448 (1969).

    PubMed  CAS  Google Scholar 

  • CLANE, R.Y.: Renal transplantation, p. 145. London: Arnold Publ. 1967.

    Google Scholar 

  • CLARKSON, B., O’CONNOR, A., WINSTON, L., HUTCHISON, D.: The physiologic disposition of 5-fluorouracil and 5-fluoro-2-deoxyuridine in man. Clin. Pharmacol. Ther. 5, 581–610 (1964).

    PubMed  CAS  Google Scholar 

  • COHEN, B.D., GALLOWAY, J.A., MCMAHON, R.E.: Carbohydrate metabolism in uremia: blood glucose response to sulfonylurea. Amer. J. med. Sei. 254, 608–618 (1967).

    Article  CAS  Google Scholar 

  • COHEN, E.N., BREWER, H. W., SMITH, D.: The metabolism and elimination of d-tubo-curarine H3. Anesthesiology 28, 309–317 (1967).

    Article  PubMed  CAS  Google Scholar 

  • COHN, E.S., GORDES, E.H., BRUSILOW, S. W.: Ethacrynic acid effect on the composition of cochlear fluids. Science 171, 910–911 (1971).

    Article  PubMed  CAS  Google Scholar 

  • COTTIER, P., HALDEMANN, G.: De l’emploi d’un sulfamide (Ro 4-4393) à durée d’action prolongée dans le traitement de la pyélonéphrite chronique. J. Urol. Néphrol. 70, 797–809 (1964).

    CAS  Google Scholar 

  • COTTER, P., REUBI, F., DUPASQUIER, E.: Die Wirkung von Guanethidin auf den Hochdruck und die Nierenfunktion bei klinischer und ambulanter Behandlung. Dtsch. med. Wschr. 85, 1263–1271 (1960).

    Google Scholar 

  • CRANDELL, W.B., PAPPAS, S.G., MACDONALD, A.: Nephrotoxicity associated with methoxy- flurane anesthesis. Anesthesiology 27, 591–607 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Curtis, J.R., Eastwood, J.B.: Colistin sulfomethate sodium administration in the presence of severe renal failure and during haemodialysis and peritoneal dialysis. Brit. med. J. 1968I, 484-485.

    Google Scholar 

  • CUTRITS, J.R., MCDONALD, S. J., WESTON, J. H.: Parenteral administration of gentamicin in renal failure: patients undergoing intermittent haemodialysis. Brit. med. J. 1967II, 537–539.

    Google Scholar 

  • DAVIDSON, H.C.C., WAY, W.L., DEJONG, R.H.: The muscle relaxants and renal excretion. Anesthesiology 28, 540–546 (1967).

    Google Scholar 

  • DAYTON, P.G., SICAM, L.E., LANDRAU, M., BURNS, J.J.: Metabolism of sulfinpyrazone (Anturane) and other thio analogs of phenylbutazone in man. J. Pharmacol, exp. Ther. 132, 287–290 (1961).

    CAS  Google Scholar 

  • DAYTON, P.G., YU, T. F., CHEN, W., BERGER, L., WEST, L. A., GUTMAN, A.B.: The physiological disposition of probenecid. J. Pharmacol, exp. Ther. 140, 278–286 (1963).

    CAS  Google Scholar 

  • DENIZOT, M., FABRE, J., POMETTA, D., WILDI, E.: Nephrotic syndrome, Clofibrate and muscular pain. Lancet 1973II, 1326.

    Google Scholar 

  • DESJACQUES, P.: Etude de la diffusion de la diphénylhydantoîne à travers la membrane de cellophane du rein artificiel chez un malade urémique et épileptique. Praxis 61, 418–423 (1972).

    PubMed  CAS  Google Scholar 

  • DESMONTS, J. M., MIGNON, F., HENNETIER, G., DIMARIA, G.: L’anesthésie au cours de l’insuffisance rénale aiguë. Anesth. Analg. Réanim. 25, 81 –92 (1968).

    CAS  Google Scholar 

  • DETTLI, L.: Dosierungstheorie für die repetierte Applikation reversibel wirkender Pharmaka bei Eliminationsinsuffizienz. In: Pharmacological and clinical Significance of Pharmacokinetics, Symposia Medica Hoechst, pp. 31–41. Stuttgart-New York: Schattauer 1970.

    Google Scholar 

  • DETTLI, L.: SPRING, P., RYTER, S.: Multiple dose kinetics and drug dosage in patients with kidney disease. In: Proc. Symposium on Biological and Pharmaceutical Aspects of Pharmacokinetics and Therapeutics, pp. 211–224. Copenhagen: Musgaard 1971.

    Google Scholar 

  • DEUTSCH, S., GOLDBERG, M., STEPHAN, G. W., WO, W.H.: The effect of halothane anesthesia on renal function in normal man. Anesthesiology 27, 793–804 (1966).

    Article  PubMed  CAS  Google Scholar 

  • DIMMLING, T., LUTZEYER, W., HÜENER, H.: Resorption und Ausscheidung von Oxytetracyclin in Abhängigkeit von der Nierenfunktion der urologischen Kranken. Arzneim.-Forsch. 7, 681–684 (1957).

    CAS  Google Scholar 

  • DOHERTY, J.E.: The clinical pharmacology of digitalis glycosides: a review. Amer. J. med. Sei. 255, 382–414 (1968).

    Article  CAS  Google Scholar 

  • DOHERTY, J.E.: FLANIGAN, W. J.: Studies with tritiated digoxin in anephric human subjects. Circulation 35, 298–302 (1967).

    PubMed  CAS  Google Scholar 

  • DOHERTY, J.E.: PERKINS, W.H., WILSON, M.C.: Studies with tritiated digoxin in renal failure. Amer. J. Med. 37, 536–543 (1964).

    Article  PubMed  CAS  Google Scholar 

  • DOHERTY, C. T.: Methyl-dopa in hypertension. Amer. Heart J. 65, 139–140 (1963).

    Article  Google Scholar 

  • DOHERTY, C. T.: SMITH, D.E., MILNE, M.D.: Clinical and pharmacological studies with guanethidine in the treatment of hypertension. Lancet 1960II, 381–387.

    Google Scholar 

  • DOST, F.H.: Grundlagen der Pharmakokinetik. Stuttgart: Thieme 1968.

    Google Scholar 

  • DRING, J. G., SMITH, R.L., WILLIAMS, R. T.: The metabolic fate of amphetamine in man and other species. Biochem. J. 116, 425–435 (1970).

    PubMed  CAS  Google Scholar 

  • DUBACH, U.C., BÜCKERT, A., FORGO, I., RENTSCH, G.: Etude pharmaco-clinique du glibornuride. Symposium international sur les agents hypoglycémiants. Evian 1971.

    Google Scholar 

  • DUBOIS-PRIMO, J., GEENS-BASTENIER, J., GENICOTT, C.: Anesthésie générale chez l’insuffisant rénal. Anesth. Anal. Réanim. 28, 343–354 (1969).

    Google Scholar 

  • DUNDEE, J.W., RICHARDS, R.K.: Effect of azotemia upon the action of intravenous barbiturate anesthesia. Anesthesiology 15, 333–346 (1954).

    Article  PubMed  CAS  Google Scholar 

  • DUPONT, P., DUCKERT, A., FABRE, J.: Modifications du métabolisme électrolytique et des fonctions glomérulaires et tubulaires sous l’influence de dérivés pyrazolés. Helv. med. Acta 19, 528–546 (1952).

    CAS  Google Scholar 

  • EASTWOOD, J. B., CURTIS, J. R.: Carbenicillin administration in patients with severe renal failure. Brit. med. J. 1968I, 486–487 (1968).

    Google Scholar 

  • EDWARDS, K. D. G., WHYTE, H. M.: Streptomycin poisoning in renal failure. An indication for treatment with an artificial kidney. Brit. med. J. 1959I, 752–754.

    Google Scholar 

  • ELION, G.B.: Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues. Fed. Proc. 26, 898–904 (1967).

    PubMed  CAS  Google Scholar 

  • ELION, G.B., Yu, T. F., GUTMAN, A.B., HITCHINGS, G. H.: Renal clearance of oxypurinol, the chief metabolite of allopurinol. Amer. J. Med. 45, 69–77 (1968).

    Article  PubMed  CAS  Google Scholar 

  • FABRE, J.: Les oedèmes pyrazoliques. Sem. Hop. Paris 30, 444–447 (1954).

    PubMed  CAS  Google Scholar 

  • FABRE, J.: Médicaments et fonctions rénales. Helv. med. Acta Suppl. 47, 24–41 (1967a).

    CAS  Google Scholar 

  • FABRE, J.: BALANT, L., ZAHND, G.: Comportement delà glipizide(sulfonylurée hypoglycémiante) dans l’insuffisance rénale. To be published in Le Diabète (1973a).

    Google Scholar 

  • FABRE, J.: DENIZOT, M., WILDI, E., MICHELI, H.: Pouvoir hypolipémiant et action myotoxique du Clofibrate en cas de syndrome néphrotique. Praxis 62, 732–737 (1973b).

    PubMed  CAS  Google Scholar 

  • FABRE, J.: de Freudenreich, J., Duckert, A., Pitton, J. S., Rudhardt, M., Virieux, C.: Influence of renal insufficiency on the excretion of chloroquine, phénobarbital, phenothiazines and methacycline. Helv. med. Acta 33, 307–316 (1967 b).

    Google Scholar 

  • FABRE, J.: Leblanc, A.: La néphrotoxicité des médicaments. In: Heusghem, C., Lechat, P.: Effets indésirables des médicaments, p. 490. Paris: Masson 1973.

    Google Scholar 

  • FABRE, J.: MERIER, G., LAURENCET, F. L., RUDHARDT, M., Chuit, A.: Behaviour of doxycycline in renal insufficiency. Helv. med. Acta 35, 124–134 (1969).

    PubMed  Google Scholar 

  • FABRE, J.: MILEK, E., KALFOPOULOS, P., MERIER, G.: La cinétique des tétracyclines chez l’homme. Schweiz, med. Wschr. 101, 593–598 and 625–633 (1971).

    Google Scholar 

  • FABRE, J.: PITTON, J. S., VIRIEUX, C., LAURENCET, F. L., BERNHARDT, J. P., GODEL, J. C.: Absorption, distribution et excrétion de la doxycycline chez l’homme. Schweiz, med. Wschr. 97, 915–924 (1967c).

    CAS  Google Scholar 

  • FALBRIARD, A., FABRE, J., ENGEL, E., DUCKERT-MAULBETSCH, A.: Les sulfamides inhibiteurs de la carboanhydrase et leur action rénale. Médecine dans le Monde 31, E7–E21 (1957).

    Google Scholar 

  • FALOON, W. W., DOWNS, J. J., DUGGAN, K., PRIOR, J. T.: Nitrogen and electrolyte metabolism and hepatic function and histology in patients receiving tetracycline. Amer. J. med. Sei. 233, 563–572 (1957).

    Article  CAS  Google Scholar 

  • FLOCK, E.V., BOLLMAN, J.L., GRINDLEY, J.H., OVIS, A.L.: Metabolism of L-thyroxine and L-triiodothyrosine in the absence of liver. Amer. J. Physiol. 187, 407–414 (1956).

    PubMed  CAS  Google Scholar 

  • FORESTIER, J.: La chrysothérapie des polyarthrites. Rhumatologie 1, 66–89 (1949).

    Google Scholar 

  • FREEMAN, R.B., MÄHER, J. F., SCHREINER, G. E., Mostofi, F.K.: Renal tubular necrosis due to nephrotoxicity of organic mercurial diuretics. Ann. intern. Med. 57, 34–43 (1962b).

    PubMed  CAS  Google Scholar 

  • FREEMAN, R.B., SHEFF, M. F., Mäher, J. F., Schreiner, G. E.: The blood cerebrospinal fluid barrier in uremia. Ann. intern. Med. 58, 233 –240 (1962a).

    Google Scholar 

  • FRIEDBERG, V., RÜBENACH, I.: Untersuchungen über die Nierenfunktion während der Narkose und Operation. Klin. Wschr. 35, 974–980 (1957).

    Article  PubMed  CAS  Google Scholar 

  • GABUZA, G.J., GOCKE, T.M., JACKSON, G.G., GRIGSBY, M.E., DEL LOVE, B., Jr., FINLAND, M.: Some effects of antibiotics on nutrition in man. Arch, intern. Med. 101, 476–513 (1958).

    Google Scholar 

  • GAUERT, W.B., BUSCHMAN, D., PARMLEY, R. T.: Renal function associated with methoxy-flurane anesthesia. S. Afr. med. J. 62, 1587–1490 (1969).

    Google Scholar 

  • GERHARDT, R. E., KNAUSS, R. F., THYRAM, P. T., LUCHI, R. J., MORRIS, J. J.: Quinidine excretion in aciduria and alkaluria. Ann. intern. Med. 71, 927–933 (1969).

    PubMed  CAS  Google Scholar 

  • GINGELL, J. C., CHISHOLM, G. D.: Renal tissue levels of gentamicin and a dose schedule in renal impairment. Ther. Umsch. suppl. 1, 38–42 (1969).

    Google Scholar 

  • GINGELL, J. C., WATERWORTH, P. M.: Dose of gentamicin in patients with normal renal function and renal impairment. Brit. med. J. 1968II, 19–22.

    Google Scholar 

  • GIROMINI, M., WASEM, R., MERIER, G., FABRE, J.: Influence de l’anurîe et des hémodialyses sur le comportement des antibiotiques. Praxis 58, 1181–1187 (1969).

    PubMed  CAS  Google Scholar 

  • GLAZKO, A.J., DILL, W.A., WOLFF, L.M.: Observations on the metabolic disposition of chloramphenicol in the rat. J. Pharmacol, exp. Ther. 104, 452–455 (1952).

    CAS  Google Scholar 

  • GLOGNER, P., LANGE, H., PFAB, R.: Tolbutamidstoffwechsel bei Niereninsuffizienz. Med. Welt 52, 2876–2878 (1968).

    PubMed  CAS  Google Scholar 

  • GOFF, J.B., SCHLEGEL, J. U., O’DELL, R.M.: Urinary excretion of nalidixic acid, sulfamethizole, and nitrofurantoin in patients with reduced renal function. J. Urol. 99, 371–375 (1968).

    PubMed  CAS  Google Scholar 

  • GOODMAN, L.S., GILMAN, A.: The pharmacological basis of therapeutics. 4th edition. New York: McMillan 1970.

    Google Scholar 

  • GOODWIN, N.J., FRIEDMAN, E.A.: The effects of renal impairment, peritoneal dialysis, and hemodialysis on serum colistimethate levels. Ann. intern. Med. 66, 984–994 (1968).

    Google Scholar 

  • GRAHAME-SMITH, D. G., EVEREST, M. S.: Measurement of digoxin in plasma and its use in diagnosis of digoxin intoxication. Brit. med. J. 1969I, 286–289.

    Google Scholar 

  • GREENBERG, P. A., SANFORD, J. P.: Removal and absorption of antibiotics in patients with renal failure undergoing peritoneal dialysis. Ann. intern. Med. 68, 465–479 (1967).

    Google Scholar 

  • GSELL, O., DUBACH, U. C, Raillard-Peucker, U.: Phenacetine Abusus und Nierenleiden. Dtsch. med. Wschr. 93, 101–108 (1968).

    CAS  Google Scholar 

  • HABIF, D.V., PAPPER, E. M., FITZPATRICK, H. F., LOWRANCE, P., SMYTHE, C., BRADLEY, S. E.: The renal and hepatic blood flow, glomerular filtration rate and urinary output of electrolytes during cyclopropane, ether and thiopental anesthesia, operation and the immediate post-operative period. Surgery 30, 241–255 (1951).

    PubMed  CAS  Google Scholar 

  • HAMBURGER, J.: Résultats de 45 homotransplantations rénales humaines. In: Actualités néphrologiques de l’Hôpital Necker, p. 83. Paris: Flammarion 1965.

    Google Scholar 

  • HENDERSON, E. S., ADAMSON, R.H., OLIVERIO, V. T.: The metabolic fate of tritiated metho¬trexate. II. Absorption and excretion in man. Cancer Res. 25, 1018–1024 (1965).

    PubMed  CAS  Google Scholar 

  • HEYMAN, A., PATTERSON, J. L., JONES, R.W.: Cerebral circulation and metabolism in uremia. Circulation 1, 558–563 (1951).

    Google Scholar 

  • HINMAN, A.R., WOLINSKY, E.: Nephrotoxicity associated with the use of cephaloridin. J. Amer. med. Ass. 200, 724–726 (1967).

    Article  CAS  Google Scholar 

  • HOFFMAN, T. A., CESTERO, R., BULLOCK, W. E.: Pharmacodynamics of carbenicillin in hepatic and renal failure. Ann. intern. Med. 73, 173–178 (1970).

    PubMed  CAS  Google Scholar 

  • HOPPER, J., Jr., JAWETZ, E., HINMAN, F., Jr.: Polymyxin B in chronic pyelonephritis: observations on the safety of the drug and on its influence on the renal infection. Amer. J. med. Sei. 225, 402–409 (1953).

    Article  CAS  Google Scholar 

  • HUANG, C.L., KURLAND, A.A.: A quantitative study of chlorpromazine and its sulfoxides in the urine of psychotic patients. Amer. J. Psychiat. 118, 428–437 (1961).

    PubMed  CAS  Google Scholar 

  • JELLIFFE, R.W.: An improved method of digoxin therapy. Ann. intern. Med. 69, 703–717 (1968).

    PubMed  CAS  Google Scholar 

  • JELLIFFE, R.W., BUELL, J., KALABA, R., SRIDHAR, R., Rockwell, R., Wagner, J. G.: An improved method of digitoxin therapy. Ann. intern. Med. 72, 453–464 (1970).

    PubMed  CAS  Google Scholar 

  • JENNE, J.W., MACDONALD, F. M., Mendoza, E.: A study of the renal clearances, metabolic inactivation rates, and serum fall-off interaction of isoniazid and para-aminosalicylic acid in man. Amer. Rev. resp. Dis. 84, 371–378 (1961).

    PubMed  CAS  Google Scholar 

  • JUNGERS, P., KLEINKNECHT, D., LOIRAT, P.: Les accidents rénaux de la céphaloridine. Presse méd. 70, 1515–1518 (1969).

    Google Scholar 

  • KABINS, S.A., COHEN, S.: Cephalothin serum levels in azotemic patient. Antimicrob. Agents Chemother. 4, 207–214 (1964).

    Google Scholar 

  • KALOWSKI, S., MATHEW, T.H., SINGHNAURA, R., KINCAID-SMITH, P.: Deterioration in renal function in association with co-trimoxazole therapy. Lancet 1973I, 394–397.

    Google Scholar 

  • KALSER, S.C., KELVINGTON, E. J., RANDOLPH, M.M., Santomenna, D.M.: Drug metabolism in hypothermia. I. Biliary excretion of C14 atropine metabolites in the intact and neph- rectomized rat. J. Pharmacol, exp. Ther. 147, 252–259 (1965).

    CAS  Google Scholar 

  • KATZ, J., SARMUB, L., KOREUTZ, COHN, R.: Anesthesic considerations for renal transplant. Anesthesia and Analgesia. Curr. Res. 48, 609–613 (1967).

    Google Scholar 

  • KEBERLE, H., HOFFMANN, K., BERNHARD, K.: The metabolism of glutethimide (Doriden). Experientia (Basel) 18, 105–111 (1962).

    Article  CAS  Google Scholar 

  • KESSLER, R.H.: Clinical pharmacology of chlorothiazide compounds. Clin. Pharmacol. Ther. 3, 109–118 (1962).

    PubMed  CAS  Google Scholar 

  • KIND, A.C., TUPAS, T.E., STANDIFORD, H.C., KIRB, W.M.M.: Mechanisms responsible for plasma levels of nafcillin lower than those of oxacillin. Arch, intern. Med. 125, 685–690 (1970).

    CAS  Google Scholar 

  • KLEINKNECHT, D., BABINET, P., GANEVAL, D. et al.: La 5-fluorocytosine dans le traitement des candidoses avec insuffisance rénale aiguë. J. Urol. Néphrol. 79, 753–755 (1973).

    CAS  Google Scholar 

  • KOCH-WESER, J., SIDEL, V.W., FEDERMAN, E.B., KANAREK, P., FINER, D.C., EATON, A.E.: Adverse effects of sodium colistimethate. Ann. intern. Med. 72, 857–868 (1970).

    PubMed  CAS  Google Scholar 

  • KOECHLIN, B. A., SCHWARTZ, M. A., KROL, G., OBERHANSLI, W.: The metabolic fate of Ci4-labeËed chlordiazepoxide in man, in the dog, and in the rat. J. Pharmacol, exp. Ther. 145, 399–411 (1965).

    Google Scholar 

  • KOIDE, M., Waüd, B.E.: Serum potassium concentration after succinylcholine in patients with renal failure. Anesthesiology 36, 142–145 (1972).

    Article  PubMed  CAS  Google Scholar 

  • KOPPEL, M.H., Shinaberger, J. H., Massry, S. G., Popovtzer, M. M., Coburn, J.W.: Hypercalcemic response to hydrochlorothiazide in uremia. Clin. Res. 17, 435 (1969).

    Google Scholar 

  • KRACKHARDT, H., von: Blutspiegel und Ausscheidung des Cycloserins bei länger dauernder Medikation. Schweiz. Z. Tuberk. 17, 403–416 (1960).

    Google Scholar 

  • KRAMER, P., WILLMS, B., HORENKAMP, J., SCHELER, F.: Blutspiegelkinetik und renal clearance von H3-Peruvosid. Klin. Wschr. 47, 1157–1166 (1969).

    Article  PubMed  CAS  Google Scholar 

  • KRüGER-THIEMER, E.: Dosage schedule and pharmacokinetics in chemotherapy. J. Amer, pharm. Ass. (Sc. ed.) 49, 311–313 (1960).

    Article  Google Scholar 

  • KRÜGER-THIEMER, E.: Pharmacokinetics and dose concentration relationships. Proc. 3rd Intern. Pharmacological Meeting. Vol. 7. Physico-chemical aspects of drug action, pp. 63–113. New York: Pergamon Press 1968.

    Google Scholar 

  • KUNIN, C. M.: Analysis of the restrictions imposed by renal failure on antibiotic therapy of pyelonephritis. In: Biology of pyelonephritis, p. 623. London: Churchill, 1960.

    Google Scholar 

  • Kunin, C. M.: A guide to the use of antibiotics in patients with renal disease. Ann. intern. Med. 67, 151–158 (1967).

    PubMed  CAS  Google Scholar 

  • KUNIN, C. M.: Atuk, N.: Excretion of cephaloridine and cephalothin in patients with renal impairment. New Engl. J. Med. 274, 654–656 (1966).

    CAS  Google Scholar 

  • KUNIN, C. M.: CHALMERS, T.C., LEEVY, C.M., SEBASTYEN, S.C., Lieber, C.S., Finland, M.: Absorption of orally administered neomycin and kanamycin. New Engl. J. Med. 262, 380–385 (1960).

    CAS  Google Scholar 

  • KUNIN, C. M.: FINKELBERG, Z.: Oral cephalexin and ampicillin: Antimicrobial activity, recovery in urine and persistence in blood of uremic patients. Ann. intern. Med. 72, 349–356 (1970).

    PubMed  CAS  Google Scholar 

  • KUNIN, C. M., FINLAND, M.: Persistence of antibiotics in blood of patients with acute renal failure. — III. Penicillin, streptomycin, erythromycin, and kanamycin. J. clin. Invest. 38, 1509–1519 (1959a).

    Article  PubMed  CAS  Google Scholar 

  • KUNIN, C. M., FINLAND, M.: Restrictions imposed on antibiotic therapy by renal failure. Arch, intern. Med. 104, 1030–1050 (1959b).

    CAS  Google Scholar 

  • KUNIN, C. M.: GLAZKO, A. J., FINLAND, M.: Persistence of antibiotics in blood of patients with acute renal failure. — II. Chloramphenicol and its metabolites in the blood of patients with severe renal disease or hepatic cirrhosis. J. clin. Invest. 38, 1498–1508 (1959 c).

    Google Scholar 

  • KUNIN, C. M.: REES, S.B., Merrill, J. P., Finland, M.: Persistence of antibiotics in blood of patients with acute renal failure. — I. Tetracycline and Chlortetracycline. J. clin. Invest. 38, 1487–1497 (1959d).

    Article  PubMed  CAS  Google Scholar 

  • KUZUCU, E. Y.: Methoxyflurane, tetracycline, and renal failure. J. Amer. med. Ass. 211, 1162–1164 (1970).

    Article  CAS  Google Scholar 

  • LAHRTZ, H., REINOLD, N.M., van ZWIETEN, P. A.: Serum concentration and urinary excretion of 3H ouabain in patients suffering from Hver or kidney diseases. Pharmacol. Clin. 1, 114–118 (1969).

    Article  CAS  Google Scholar 

  • LAMBERT, C. R.: Nouveau traitement des schistosomiases et de l’amibiase, le Ciba 32.644-Ba (Ambilhar.). Acta trop. 23, 1–80 (1966).

    PubMed  CAS  Google Scholar 

  • LANGECKER, H., WITZGALL, H.: Beziehung zwischen Stoffwechselvorgängen und renalen Ausscheidungsmodus bei Sulfonamide. Klin. Wschr. 40, 32–34 (1962).

    Article  PubMed  CAS  Google Scholar 

  • LAPIDES, J., ALKEMA, H.D., MCDONALD, L. P., SLOAN, J.B., Zierdt, D., Herwig, K., Petrone, A.F.: Correlation of urinary output with serum and spinal fluid mannitol levels in normal and azotemic patients. J. Urol. 99, 662–669 (1968).

    PubMed  CAS  Google Scholar 

  • LARENG, Bausillon, Caillard: Insuffisance rénale et anesthésie. Anesth. Anaig. 27, 37–80 (1970).

    Google Scholar 

  • LASSEN, J.B., NIELSEN, D.E.: Investigations into the diuretic effect and elimination of triamterene. Acta Pharmacol. Toxicol. 20, 309–316 (1963).

    CAS  Google Scholar 

  • LAST, P.M., SHERLOCK, S.: Systemic absorption or orally administered neomycin in liver disease. New Engl. J. Med. 262, 385–389 (1960).

    CAS  Google Scholar 

  • LAWRASON, F.D., ALPERT, E., MOHR, F.L., MCMAHON, F. G.: Ulcerative obstructive lesions of the small intestine. J. Amer. med. Ass. 191, 641–644 (1965).

    Article  CAS  Google Scholar 

  • LHERMITTE, F., FRITEL, D., CAMBIER, J., MARTEAU, R., Gautier, J. C, Nocton, F.: Poly¬névrite au cours de traitements par la nitrofurantoïne. Presse méd. 71, 767–770 (1963).

    PubMed  CAS  Google Scholar 

  • LINBERG, A. A., NILSSON, L.H., BUCHT, H., KALLINGS, L.O.: Concentration of chloramphenicol in the urine and blood in relation to renal function. Brit. med. J. 1966II, 724–728 (1966).

    Google Scholar 

  • LINDHOLM, D.D., MURRAY, J.S.: Persistence of vancomycin in the blood during renal failure and its treatment by hemodialysis. New Engl. J. Med. 274, 1047–1051 (1966).

    CAS  Google Scholar 

  • LINDHOLMER, B., NAYM, E., RAF, L.: Nonspecific stenosing ulceration of small bowel. Acta chir. scand. 128, 310–311 (1964).

    PubMed  CAS  Google Scholar 

  • LINE, D.H., POOLE, G..W, WATERWORTH, P.M.: Serum streptomycin levels and dizziness. Tubercle (Lond.) 51, 76–81 (1970).

    CAS  Google Scholar 

  • LINQUIST, J.A., SIDDIQUI, J. Y., SMITH, I.M.: Cephalexin in patients with renal disease. New Engl. J. Med. 283, 720–723 (1970).

    CAS  Google Scholar 

  • LIPMANN, R. W., MARTI, H. U.: Effect of renal function on excretion of sulfadimetine given in small doses for urinary infection. J. Urol. 70, 548–551 (1953).

    Google Scholar 

  • LISSAC, J., AMIEL, C., MOREL-MAROGER, L., MIGNON, F.: Néphrite interstitielle aiguë due à une intoxication massive et prolongée par le méthane sulfonate de Colistine. J. Urol. Néphrol. 70, 789–797 (1964).

    CAS  Google Scholar 

  • LOCKERT, S.: Haemodialysis in the treatment of acute poisoning. Proc. roy. Soc. Med. 63, 427–430 (1970).

    Google Scholar 

  • LOURIA, D.B.: Some aspect of the absorption, distribution and excretion of amphotericin B in man. Antibiot. Med. CHn. Ther. 5, 295–301 (1958).

    CAS  Google Scholar 

  • MANIGARD, G., AUZEPY, P., LARDY, C.: Un cas d’intolérance grave au cours d’un traitement par la phénindione: mesures préventives à prendre. Sem. Hôp. Paris 44, 3217–3222 (1968).

    Google Scholar 

  • MANNHART, M., DETTLI, L., SPRING, P.: Die Elimination des Doxyzyklins und ihre Beeinflussung durch die Hämodialyse bei anurischen Patienten. Schweiz, med. Wschr. 101, 123–127 (1971).

    CAS  Google Scholar 

  • MARCUS, F.I., PETERSON, A., SALEI, A.: The metabolism of tritiated digoxin in renal insufficiency in dogs and man. J. Pharmacol, exp. Ther. 152, 372–382 (1966).

    CAS  Google Scholar 

  • MAREN, T.H., MAYER, E., WADSWORTH, B. C.: Carbonic anhydrase inhibition. I. The pharmacology of Diamox. Bull. Hopkins Hosp. 95, 199–243 (1954).

    CAS  Google Scholar 

  • MARK, L.C., KAYDEN, H. J., STEEL, J.M., COOPER, J. R., Berlin, I., Rovenstein, E.A., Brodie, B.B.: The physiologic disposition and cardiac effects of procaine amide. J. Pharmacol, exp. Ther. 102, 5–15 (1951).

    CAS  Google Scholar 

  • MASCITELLI-CORIANDOLI, E.: In: Mueckter, H.: Zur Pharmakologie der basischen Streptomyces-Antibiotika. Antibiot. Chemother. 9, 83–114 (1961).

    Google Scholar 

  • MASCITELLI-CORIANDOLI, E., BOLDRINI, R., CITTERIO, C.: Abnahme des Gehaltes von Coenzym A in Leber und Nieren bei experimenteller Nephrose. Naturwissenschaften 45, 442–456 (1958).

    Article  CAS  Google Scholar 

  • MAST, W.H.: Neuropathy due to furaltaden. New Engl. J. Med. 263, 963 (1960).

    Google Scholar 

  • MATHOG, R.H., KLEIN, W.J.: Ototoxicity of ethacrynic acid and aminoglycoside antibiotics in uremia. New Engl. J. Med. 280, 1223–1224 (1969).

    CAS  Google Scholar 

  • MATZ, G. J., NANTON, R.F.: Ototoxic drugs and poor renal function. J. Amer. med. Ass. 208, 2119 (1968).

    Article  Google Scholar 

  • MA WER, G. E., KNOWLES, B.R., LUCAS, S. B., STIRLAND, R.M.: Computer-assisted precribing of kanamycin for patients with renal insufficiency. Lancet 1972I, 12–15 (1972a).

    Google Scholar 

  • MAWER, G.E., LUCAS, S.B.: Normogramfor kanamycin dosage. Lancet 1972II, 45 (1972b).

    Google Scholar 

  • MCCHESNEY, E. W., FROELICH, E. J., LESHER, G.Y.: Nalidixic acid. Absorption, excretion and metabolism. Toxic, appl. Pharmacol. 6, 292–309 (1964).

    CAS  Google Scholar 

  • MCCLOSCKEY, R.V., HAYES, C.P.: Plasma levels of dicloxacillin in oliguric patients and the effect of hemodialysis. Antimicrob. Agents Chemother. 7, 770–772 (1967).

    Google Scholar 

  • MCHENRY, M.C., GAVAN, T.L., GIFFORD, R. W.: Gentamicin dosages for renal insufficiency: adjustments based on endogenous creatinine clearance and serum creatinine clearance and serum creatinine concentration. Ann. intern. Med. 74, 192–197 (1971).

    PubMed  CAS  Google Scholar 

  • McKay, D.N., KAYE, D.: Serum concentrations of Colistin in patients with normal and impaired renal function. New Engl. J. Med. 270, 394–397 (1964).

    Google Scholar 

  • MELLETT, L. B., HODGSON, P. E., WOODS, L. A.: Absorption and fate of C14-labeled thio-TEPA in humans and dogs. J. Lab. clin. Med. 60, 818–825 (1962).

    PubMed  CAS  Google Scholar 

  • MELLK, H.M., LETTERI, J.M., DURANTE, P.: Diphenylhydantoin metabolism in chronic uremia. Ann. intern. Med. 72, 801 (1970).

    Google Scholar 

  • MERIER, G., RUDHARDT, M., HERRERA, A., WASEM, R., FABRE, J.: Le comportement de l’oxytétracycline en cas d’insuffisance rénale. Schweiz, med. Wschr. 100, 1442–1446 (1970).

    CAS  Google Scholar 

  • MICHAEL, A. F., VERNIER, R.L., DRUMMOND, K. N.: Immunosuppressive therapy of chronic renal disease. New Engl. J. Med. 276, 817–828 (1967).

    CAS  Google Scholar 

  • MILES, B.E., De WARDENER, H. E., CHURCHILL-DAVIDSON, H. C., WYLIE, W.D.: Effect on renal circulation of pentamethonium bromid anesthesia. Clin. Sei. 11, 73–79 (1952).

    CAS  Google Scholar 

  • MILLER, R.D., BATES, J.H.: Amphotericin B toxicity. Ann. intern. Med. 71, 1089–1095 (1969).

    PubMed  CAS  Google Scholar 

  • MILLER, R.D., WAY, W.L., HAMILTON, W. H., LAZZER, R.B.: Succinylcholine-induced hyperkaliemia in patients with renal failure. Anesthesiology 36, 138–141 (1972).

    Article  PubMed  CAS  Google Scholar 

  • MILNE, M. D., ROWE, G. G., SOMERS, K., MUEHRCKE, R. C., Crawford, M. A.: Observations on the pharmacology of mecamylamine. Clin. Sei. 18, 599–614 (1957).

    Google Scholar 

  • MOLLARET, P., MÖNS ALLIER, J. F., POCIDALO, J. J., Rapin, M.: Etudes sur l’intoxication barbiturique aiguë. — I. Les effets des variations de l’équilibre acide-basique sur la répartition du phénobarbital dans l’organisme du chien néphrectomisé. Rev. franç. Etudes clin. Biol. 4, 575–581 (1959).

    PubMed  CAS  Google Scholar 

  • MORGENSTERN, L., FREILICH, M., PANISH, J. F.: The circumferantial smallbowel ulcer. J. Amer. med. Ass. 191, 637–640 (1965).

    Article  CAS  Google Scholar 

  • MUECKTER, H.: Zur Pharmakologie des basischen Streptomyces-Antibiotika. Antib. Chemother. 9, 83–114 (1961).

    Google Scholar 

  • MURPHY, K.J.: Uraemic accentuation of chlorpromazine pigmentation. Med. J. Austr. 2, 1228–1229 (1966).

    CAS  Google Scholar 

  • NOWELL, P. T., SCOTT, C. A., WILSON, A.: Hydrolisis of neostigmine by plasmacholinesterase. Brit. J. Pharmacol. 18, 498–502 (1962).

    Google Scholar 

  • O’BRIEN, J.P., SHARP, A.R., Jr.: The influence of renal disease on the insulin (I131) disappearance curve in man. Metabolism 16, 76–83 (1967).

    Article  PubMed  Google Scholar 

  • Odar-Cederlöf, I., Lunde, P., SJÖQVIST, F.: Abnormal pharmacokinetics of phenytoin in a patient with uremia. Lancet 1970II, 831–832.

    Google Scholar 

  • OGG, C.S., TOSELAND, P. A., CAMERON, J.S.: Pulmonary tuberculosis, in patient on hemodialysis. Brit. med. J. 1968II, 283–284.

    Google Scholar 

  • O’GRADY, F.: Antibiotics in renal failure. Brit. med. Bull. 27, 142–147 (1971).

    Google Scholar 

  • OKITA, G.T., Talso, P. J., CURRY, J.H., SMITH, F.D., GELLING, E.M.K.: Metabolic fate of radioactive digitoxin in human subjects. J. Pharmacol, exp. Ther. 115, 371–379 (1955).

    CAS  Google Scholar 

  • OLSEN, S.: The brain in uremia. Acta psychiat. scand. 36, Suppl. 156, 1–128 (1961).

    Google Scholar 

  • ONESTI, G., BOCK, K.D., HEIMSOTH, V.: Clonidine: a new antihypertensive agent. Amer. J. Cardiol. 28, 74–83 (1971).

    Article  PubMed  CAS  Google Scholar 

  • ORME, B.M., CUTLER, R.E.: The relationship between kanamycin pharmacokinetics, distribution and renal function. Clin. Pharmacol. Ther. 10, 543–550 (1969).

    PubMed  CAS  Google Scholar 

  • OTTO, G.F., MAREN, T.H., BROWN, H.W.: Blood levels and excretion rates of antimony in persons receiving trivalent antimonials. Amer. J. Hyg. 45, 193–211 (1947).

    Google Scholar 

  • PAPAC, R., CREASY, W.A., CALABRESI, P., WELCH, A.D.: Clinical and pharmacological studies with I-B-arabinofuranosylcytosine (cytosine arabinoside). Proc. Amer. Ass. Cancer Res. 6, 50 (1965).

    Google Scholar 

  • PAPPER, E.M.: Renal function during general anesthesis and operation. J. Amer. med. Ass. 152, 1686–1689 (1953).

    Article  CAS  Google Scholar 

  • PAUL, M. F., PAUL, H. E., KOPKO, F., BRYSON, M. J., Harrington, C.: Inhibition by furacin of citrate formation in testis preparation. J. biol. Chem. 208, 491–497 (1954).

    Google Scholar 

  • PAYET, M., SANKALE, M.: Hyperazotémies transitoires consécutives au traitement de la trypanosomiase humaine africaine avec des diamidines. Bull. Soc. path. Exot. 53, 690–696 (1960).

    CAS  Google Scholar 

  • PEETS, E.A., SWEENEY, W. M., PLACE, V. A., BUYSKE, D.A.: The absorption, excretion, and metabolic fate of ethambutol in man. Amer. Rev. Resp. Dis. 91, 51–58 (1965).

    PubMed  CAS  Google Scholar 

  • PERKINS, P. L., SMITH, E. J., SASLAW, S.: Cephalothin and cephaloridine: comparative pharmacodynamics in chronic uremia. Amer. J. Med. Sei. 257, 116–124 (1969).

    Article  CAS  Google Scholar 

  • PETITPIERRE, B., FABRE, J.: Effet de l’insuffisance rénale sur l’action hypoglycémiante des sulfonylurées. Cinétique de la chlorpropamide en cas de néphropathie. Schweiz, med. Wschr. 102, 570–578 (1972).

    Google Scholar 

  • PETITPIERRE, B., PERRIN, L., RUDHARDT, M., HERRERA, A., FABRE, J.: Behavior of chlorpropamide in renal insufficiency and under the effect of associated drug therapy. Int. J. Pharmacol. 6, 120–124 (1972).

    CAS  Google Scholar 

  • PEZZI, P. I., FROBESE, A.S., GREENBERG, S. R.: Methoxyflurane and renal toxicity. Lancet 1966I, 823.

    Google Scholar 

  • PILLAY, V.K.G., SCHWARTZ, F.D., AIMI, K.: Transient and permanent deafness following treatment with ethacrynic acid in renal failure. Lancet 1969I, 77–79.

    Google Scholar 

  • PLACE, V.A., THOMAS, J.P.: Clinical pharmacology of ethambutol. Amer. Rev. resp. Dis. 87, 901–904(1963).

    Google Scholar 

  • PLAUT, M. E., O’CONNELL, C. J., PABICO, R. C, Davidson, D.: Penicillin handling in normal and azotemic patients. J. Lab. clin. Med. 74, 12–18 (1969).

    PubMed  CAS  Google Scholar 

  • PLETKA, P., COHEN, S.L., KENYON, J. R., SNELL, M.: Cadaveric renal transplantation. An analysis of 65 cases. Lancet 1969I, 1–6 (1969).

    Google Scholar 

  • POHL, J.E., THURSTON, H.: Use of diazoxide in hypertension with renal failure. Brit. med. J. 1971IV, 142–145 (1972).

    Google Scholar 

  • POLLAK, V. E.: Anticoagulants in the treatment of renal disease. Ann. intern. Med. 73, 334–335 (1970).

    PubMed  CAS  Google Scholar 

  • POWELL, J.N.: Suxamethonium-induced hyperkaliemia in a uraemic patient. Brit. J. Anesth. 42, 806–807 (1970).

    Article  Google Scholar 

  • PRESCOTT, L.F.: Effects of acetylsalicyclic acid, phenacetin, paracetamol and caffeine on renal tubular epithelium. Lancet 1965II, 91–96.

    Google Scholar 

  • PRESCOTT, L.F.: The metabolism of phenacetin in patients with renal diseases. Clin. Pharmacol. Ther. 10, 383–394 (1969).

    PubMed  CAS  Google Scholar 

  • RAABLAUF, J., DUBACH, U. C.: Dose-dependant change in the pattern of phenacetin metabolism in man and its possible significance in analgesic nephropathy. Klin. Wschr. 47, 1286–1287 (1969).

    Article  Google Scholar 

  • RABINOWITZ, P., FRIEDMAN, I. S.: Drug-induced lactation in uremia. J. clin. Endoer. 21, 1489–1493 (1961).

    Article  CAS  Google Scholar 

  • RABKIN, R., SIMON, N.M., STEINER, S., COLWELL, J.A.: Effect of renal disease on renal uptake and excretion of insulin in man. New Engl. J. Med. 282, 182–187 (1970).

    CAS  Google Scholar 

  • RAHN, K.H., DAYTON, P. G.: Studies on the metabolism of guanethidine in hypertensive patients. Biochem. Pharmacol. 18, 1809–1916 (1969).

    Article  PubMed  CAS  Google Scholar 

  • REGAMEY, C., HUMAIR, L.: Pharmacokinetics of cephalexin in renal insufficiency. Postgrad, med. J. 47, suppl., 69–78 (1971).

    Google Scholar 

  • REIDENBERG, M.M.: Renal function and drug action. Philadelphia-London-Toronto: W. B. Saunders Comp. 1971.

    Google Scholar 

  • REIDENBERG, M.M., KOSTENBAUDER, H., ADAMS, W.: Rate of drug metabolism in obese volunteers before and during starvation and in azotemic patients. Metabolism 18, 209–123 (1969).

    Article  PubMed  CAS  Google Scholar 

  • REIDENBERG, M.M., ODAR-CEDERLÖF, I., VON BAHR, C., BORGA, O., SJÖQVIT, F.: Protein binding of diphenyl-hydantoin and desmethylimipramine in plasma from patients with poor renal function. New Engl. J. Med. 285, 265–267 (1971).

    Google Scholar 

  • REINARZ, J.A., MCINTOSH, D. A.: Lincomycin excretion in patients with normal renal function, severe azotemia, and with hemodialysis and peritoneal dialysis. Antimicrob. Agents Chemother. 5, 232–238 (1965).

    PubMed  CAS  Google Scholar 

  • REUBI, F.: Blutspiegel, Ausscheidung und Dosierung von N-pyrrolidino-methyltetracyclin (PMT, Reverin) bei Nierenkranken. Klin. Wschr. 45, 133–137 (1967).

    Article  PubMed  CAS  Google Scholar 

  • REUBI, F., COTTIER, P. T.: Effects of reduced glomerular filtration rate on responsiveness to chlorothiazide and mercurial diuretic. Circulation 23, 200–210 (1961).

    PubMed  CAS  Google Scholar 

  • REUBI, F., MÜNGER, C.: Renale and extrarenale Ausscheidung von N-pyrroHdino-methyltetracyclin (Reverin) bei Patienten mit normaler und eingeschränkter Nierenfunktion. Pharmacol. Clin. 1, 8–18 (1968).

    Article  Google Scholar 

  • REUBI, F., VORBURGER, C.: Renale und extrarenale Ausscheidung von Ampicillin bei Patienten mit normaler und eingeschränkter Nierenfunktion. Pharmacol. Clin. 1, 192–202 (1969).

    Article  Google Scholar 

  • REUBI, F., COTTIER, P. T., BÜTIKOFER, E.: A comparison of the short-term and long-term haemodynamic effects of antihypertensive therapy. In Catapress in Hypertension, pp. 113–136. London: Conolly and Butterworths 1970.

    Google Scholar 

  • RICHARDS, R.K., TAYLOR, J. D., KUETER, K.E.: Effect of nephrectomy on the duration of sleep following administration of thiopental and hexobarbital. J. Pharmacol, exp. Ther. 108, 461–473 (1953).

    CAS  Google Scholar 

  • RICHARDSON, J. A., DERROW, A.M., BORCHARDT, K. A.: Therapy with amphotericin B of Candida septicemia in the presence of acute renal failure. Invest. Urol. 8, 247–250 (1968).

    Google Scholar 

  • RICHET, G., ARDAILOU, R., FILLASTRE, J.P., BLAISE, P.: Sécrétion gastrique de Furémique. Rev. franç. Etude clin. Biol. 10, 180–190 (1965).

    Google Scholar 

  • RICHET, G., ARDAILOU, R., SULTAN, Y.: Accidents neuro-psychiques chez des urémiques chroniques traités par le méthane-suifonate de Colistine. Bull. Mém. Soc. méd. Hôp. Paris 113, 1199–1205 (1962).

    PubMed  CAS  Google Scholar 

  • RICHET, G., AUROUSSEAU, M., EMMERICH: Toxicité du méthane sulfonate de Colistine chez le rat en réduction néphronique. In: Richet, G., Fabre, J., de Freudenreich, J., Podevin, R.: La tolérance médicamenteuse au cours de l’insuffisance rénale, pp. 12–17. Paris: Masson 1966a.

    Google Scholar 

  • RICHET, G., FABRE, J., de FREUDENREICH, J., PODEVIN, R.: La tolérance médicamenteuse au cours de l’insuffisance rénale. Paris: Masson 1966b; and J. Urol. Néphrol. 72, 257–302 (1966b).

    Google Scholar 

  • RICHET, G., VACHON, F.: Les troubles neuro-psychiques de l’urémie chronique. Bull. Mém. Soc. méd. Hôp. Paris 116, 1253–1272 (1965).

    PubMed  Google Scholar 

  • RIEDER, J., FERNEX, M., SCHWARTZ, D.E.: Pharmacokinetic data on the combination sulfamethoxasole plus trimethoprim in patients with renal impairment. Int. Congr. Chemother. 7, A-l/29 (1971).

    Google Scholar 

  • RIFF, L.J., JACKSON, G. G.: Pharmacology of gentamicin in man. J. infect. Dis. 124 (suppl.), 98–105 (1971).

    Article  Google Scholar 

  • ROELSEN, E.: Polyneuritis after nitrofurantoin therapy. Acta med. scand. 175, 145–154 (1964).

    Article  PubMed  CAS  Google Scholar 

  • ROGERS, E.W.: Excretion of piperazine salts in urine. Brit. med. J. 1958I, 136–137.

    Google Scholar 

  • ROLLY, G., VERSCHRAEGEN, R.: L’anesthésie pour la transplantation rénale. Expérience de 29 cas de transplantation avec des reins de cadavre. Anesth. Analg. Réan. 28, 355–361 (1969).

    Google Scholar 

  • ROSSUM, J.M.Van: Pharmacokinetics of accumulation. J. pharm. Sei. 57, 2162–2165 (1968).

    Article  Google Scholar 

  • ROTH, F., WÜTHRICH, H.: The clinical importance of hyperkaliema following suxamethoni¬um administration. Brit. J. Anesth. 41, 311–316 (1969).

    Article  CAS  Google Scholar 

  • SACHS, J., GEER, T., NOELL, P., KUNIN, C. M.: Effect of renal function on urinary recovery of orally administered nitrofurantoin. New Engl. J. Med. 278, 1032–1035 (1968).

    CAS  Google Scholar 

  • SACHS, J., HENDERSON, R.R.: Use of bishydroxycoumarin (Dicumarol) in the presence of impaired renal function. J. Amer. med. Ass. 148, 839–841 (1952).

    Article  CAS  Google Scholar 

  • SCHEINBERG, G.: Effects of uremia on cerebral blood flow and metabolism. Neurology 4, 101–105 (1954).

    PubMed  CAS  Google Scholar 

  • SCHEITLIN, W., JEANNERET, P.: Über akute Nierenschädigungen unter Phenylbutazon-therapie. Schweiz, med. Wschr. 87, 881–885 (1957).

    CAS  Google Scholar 

  • SCHELER, F.Von, WIGGER, W., HOFFLER, D., QUELLHORST, E.: Steigerung der Digitalistoxizität bei eingeschränkter Nierenfunktion. Dtsch. med. Wschr. 90, 1614–1620 (1965).

    Google Scholar 

  • SCHEINER, G.E., MÄHER, J.F.: Toxic nephropathy. Amer. J. Med. 38, 409–449 (1965).

    Article  Google Scholar 

  • SCHEINER, W. J., BECKER, E.L.: Acute transient hearing loss after ethacrynic acid therapy. Arch, intern. Med. 117, 715–717 (1966).

    Google Scholar 

  • SCHULTZ, J. C, ADAMSON, J. S., WORKMAN, W. W., NORMAN, T.D.: Fatal liver disease after intravenous administration of tetracycline in high dosage. New Engl. J. Med. 269, 999–1004 (1963).

    CAS  Google Scholar 

  • SCHWARTZ, G.H., DAVID, D.S., RIGGIO, R.R., STENGEL, K.H., RUBIN, A.L.: Ototoxicity induced by Furosemid. New Engl. J. Med. 282, 1413–1414 (1970).

    CAS  Google Scholar 

  • SELLERS, E.M., KOCH-WESER, J.: Protein binding and vascular activity of diazoxide. New Engl. J. Med. 281, 1141–1145 (1969).

    CAS  Google Scholar 

  • SELYE, H., PRIORESCHI, P., CANTIN, M.: Factors that determine the production of cardiovascular and renal lesions by polymyxin. Antibiot. Chemother. 11, 12–25 (1961).

    PubMed  CAS  Google Scholar 

  • SHAND, D.S., NUCKOLS, E.M., DATES, J. A.: Plasma propranolol levels in adults. With observations in four children. Clin. Pharmacol. Ther. 11, 112–120 (1970).

    PubMed  CAS  Google Scholar 

  • SHILS, M.E.: Renal disease and the metabolic effects of tetracycline. Ann. intern. Med. 58, 389–408 (1963).

    PubMed  CAS  Google Scholar 

  • SIMON, N.M., del GRECO, F., DIETZ, A.A., Rubinstein, H. M.: Serum Cholinesterase deficiency in renal failure. Trans. Amer, Soc. artif. intern. Organs 15, 328–331 (1969).

    CAS  Google Scholar 

  • SMITH, C. C., IHRIG, J.: Persistent excretion of pyrimethamine following oral administration. Amer. J. trop. Med. 8, 60–62 (1959).

    PubMed  CAS  Google Scholar 

  • SMITH, J. W., SEIDL, L.G., CLUFF, L.E.: Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility. Ann. intern. Med. 65, 629–640 (1966).

    CAS  Google Scholar 

  • SMITH, T.W., BUTLER, Y. P., HABER, P.: Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. New Engl. J. Med. 281, 1212–1216 (1969).

    CAS  Google Scholar 

  • SPRING, P.: The pharmacokinetics of Rimactane in patients with impaired liver and kidney function. Symposium on Rimactane, pp. 32–34. Bâie: Ciba 1968.

    Google Scholar 

  • SPÜHLER, P., ZOLLINGER, H.U.: Die chronische interstitielle Nephritis. Z. klin. Med. 151, 1–50 (1963).

    Google Scholar 

  • STAMEY, T.A., NEMOY, N. J., HIGGINS, M.: The clinical use of nalidixic acid. Invest. Urol. 6, 582–592 (1969).

    PubMed  CAS  Google Scholar 

  • STARZL, T.E.: Experience in renal transplantation, p. 180 and 360. Philadelphia-London-Toronto: Saunders 1964.

    Google Scholar 

  • STRUNIN, L.: Some aspects of anesthesia for renal homotransplantation. Brit. J. Anaesth. 38, 812–822 (1966).

    Article  PubMed  CAS  Google Scholar 

  • SWINYARD, W. A., WEAVER, L.C., GOODMAN, L. S.: Effect of liver injury and nephrectomy on the anticonvulsivant activity of clinically useful hydantoins. J. Pharmacol, exp. Ther. 104, 309–316 (1952).

    CAS  Google Scholar 

  • TAVERNIER, M., DUBOUCHET, N., VAYSSE, M.I.: Problèmes d’anesthésie et de réanimation peropératoire posés par la transplantation rénale chez l’homme. Anesth. Analg. Réan. 22, 129–137 (1965).

    CAS  Google Scholar 

  • TIFFENEAU, M., LEVY, J., BROUN, D.: Influence des variations de la réserve alcaline et du pH sur quelques actions pharmacodynamiques centrales ou périphériques. Arch. int. Pharmacodyn. 38, 463–467 (1930).

    Google Scholar 

  • TOBIAN, L., BINION, J.: Effect of deficiency of renal tissue with or without resulting hypertension on the electrolyte composition of brain and skeletal muscle. Amer. J. Physiol. 178, 233–236 (1954).

    PubMed  CAS  Google Scholar 

  • TONNESEN, M.: The excretion of atropine and allied alkaloids in urine. Acta pharmacol. toxicol. 6, 147–164 (1950).

    Article  CAS  Google Scholar 

  • TOURKANTONIS, A., FRIEDRICH, H., HEINZE, V.: Ampicillin-Nebenwirkung bei Patienten mit Niereninsuffizienz. Med. Klin. 66, 1154–1161 (1971).

    PubMed  CAS  Google Scholar 

  • TOUSSAINT, C., BRAUMAN, J., SMULDERS, J., LAMBERT, P. P.: Anurie mortelle par phénylbutazone. Livre jubilaire du Pr P. Govaerts, p. 86. Bruxelles: Imprimerie médicale et scientifique 1955.

    Google Scholar 

  • TRAEGER, J., ZECH, P., TOUBOUL, P.: Les complications rénales toxi-allergiques des traitements anticoagulants par la phenyl-indane-dione. Thérapie 23, 511 (1968).

    PubMed  CAS  Google Scholar 

  • UEDA, H., SAKURAI, T., OTA, M., NAKAJIMA, A., KAMII, K., MAEZAWA, H.: Disappearance rate of tolbutamide in normal subjects and in diabetes mellitus, liver cirrhosis and renal disease. Diabetes 12, 414–419 (1963).

    PubMed  CAS  Google Scholar 

  • UPDIKE, S. J., HARRINGTON, A. R.: Acute diabetic keto-acidosis — a complication of intravenous diazoxide treatment for refractory hypertension. New Engl. J. Med. 280, 768 (1969).

    CAS  Google Scholar 

  • VECSEI, P., KEMENY, V.: The effect of experimental uremia on the disappearance of prednisolone in white rats. Med. exper. 8, 35–38 (1963).

    CAS  Google Scholar 

  • VERBECKMOES, R.: Etude de la tolérance de l’acide nalidixique chez les insuffisants rénaux. J. Urol. Néphrol. 72, 303–305 (1966).

    Google Scholar 

  • VIC-DUPONT, MONSALLIER, J. F., VACHON, F., ROCHANT, H.: Incidences rénales des traitements parle méthane-suifonate de colistine. Bull. Mém. Soc. méd. Hôp. Paris 116, 25–37 (1965).

    Google Scholar 

  • VREE, T. B.: Kinetics of distribution and metabolism of amphetamines and phentermines in man and animals. Intern. Congress Pharmacol. 4, 453 (1969).

    Google Scholar 

  • WAY, E.L., ADLER, T. K.: The pharmacologic implications of the fate of morphine and its surrogates. Pharm. Rev. 12, 383–446 (1960).

    PubMed  CAS  Google Scholar 

  • WEINER, I.M., MUDGE, G. H.: Renal tubular mechanisms for excretion of organic acids and bases. Amer. J. Med. 36, 743–762 (1964).

    Article  PubMed  CAS  Google Scholar 

  • WEINSTEIN, L., LERNER, P. I., CHEW, W.H.: Clinical and bacteriologic studies of the effect of “massive” doses of penicillin G on infections caused by gramnegative bacilli. New Engl. J. Med. 271, 525–533 (1964).

    CAS  Google Scholar 

  • WEISS, P., HERSEY, R. M., DUJORNE, C.A., BIANCHINE, J. R.: The metabolism of amiloridine hydrochloride in man. Clin. Pharmacol. Ther. 10, 401–406 (1969).

    PubMed  CAS  Google Scholar 

  • WERNER, C. A., ADAMS, C., DUBOIS, R.: Absorption and excretion of viomycin in humans. Proc. Soc. exp. Biol. (N. Y.) 76, 292–295 (1951).

    CAS  Google Scholar 

  • WHALLEY, P. J., ADAMS, R.H., COMBES, B.: Tetracyclin toxicity in pregnancy. Liver and pancreatic dysfunction. J. Amer. med. Ass. 189, 357–362 (1964).

    Article  CAS  Google Scholar 

  • WILFERT, J.N., BURKE, J.P., BLOOMER, H.A., SMITH, C.B.: Renal insufficiency associated with gentamicin therapy. J. infect. Dis. 124, suppl. S 148–S 153 (1971).

    Google Scholar 

  • WILLIAMS, O.M., WIMPENNY, J., ASSCHER, A.W.: Renal clearance of sodium sulphadimidine in normal and uraemic subjects. Lancet 1968II, 1058–1060.

    Google Scholar 

  • WOLINSKI, E., HINES, J.D.: Neurotoxic and nephrotoxic effects of colistin in patients with renal disease. New Engl. J. Med. 268, 759–762 (1962).

    Google Scholar 

  • WOODRUFF, M.F. A., NOLAN, B., ROBSON, J. S., McDonald, M.K.: Renal transplantation in man. Experience in 35 cases. Lancet 1969I, 6–12.

    Google Scholar 

  • WOODS, J. W., BLYTHE, W.B.: Management of malignant hypertension complicated by renal insufficiency. New Engl. J. Med. 277, 57–61 (1967).

    CAS  Google Scholar 

  • WRIGHT, W.W., PUTNAM, L.E., WELCH, H.: Novobiocin: serum concentrations and urinary excretion following oral administration in man. Antibiot. Med. 2, 311–316 (1956).

    PubMed  CAS  Google Scholar 

  • WYANT, S.M.: The anesthesist looks at tissue transplantation: three years’ experience with kidney transplant. Canad. Anaesth. Soc. J. 14, 255–275 (1967).

    Article  PubMed  CAS  Google Scholar 

  • YOUNG, I. M., DEWARDENER, H. E., MILES, B.E.: Mechanism of the renal excretion of methonium compounds. Brit. med. J. 1951II, 1500–1501.

    Google Scholar 

  • YOW, E.M., MOYER, J.H.: Toxicity of polymyxin B. Arch. intern. 92, 248–257 (1953).

    Article  CAS  Google Scholar 

Download references

Authors
  1. Jean Fabre
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Irving Ohr
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

P. Frick G.-A. von Harnack G. A. Martini A. Prader R. Schoen H. P. Wolff

Rights and permissions

Reprints and permissions

Copyright information

© 1974 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Fabre, J., Ohr, I. (1974). Drug Selection and Dosage in Renal Insufficiency. In: Frick, P., von Harnack, GA., Martini, G.A., Prader, A., Schoen, R., Wolff, H.P. (eds) Ergebnisse der Inneren Medizin und Kinderheilkunde. Ergebnisse der Inneren Medizin und Kinderheilkunde. Neue Folge Advances in Internal Medicine and Pediatrics, vol 34. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65746-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-65746-7_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-65748-1

  • Online ISBN: 978-3-642-65746-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation